Carl Zeiss Meditec AG (ETR:AFX) has been given an average rating of “Hold” by the ten ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is €59.61 ($67.74).

A number of research analysts recently issued reports on the company. Commerzbank set a €51.00 ($57.95) price objective on Carl Zeiss Meditec and gave the company a “neutral” rating in a research note on Wednesday, August 8th. Independent Research set a €73.00 ($82.95) price objective on Carl Zeiss Meditec and gave the company a “neutral” rating in a research note on Monday, August 13th. Hauck & Aufhaeuser set a €69.00 ($78.41) price objective on Carl Zeiss Meditec and gave the company a “neutral” rating in a research note on Tuesday. Deutsche Bank set a €65.00 ($73.86) price objective on Carl Zeiss Meditec and gave the company a “neutral” rating in a research note on Tuesday, August 14th. Finally, Berenberg Bank set a €55.00 ($62.50) price objective on Carl Zeiss Meditec and gave the company a “neutral” rating in a research note on Tuesday, May 15th.

Shares of ETR:AFX opened at €74.70 ($84.89) on Friday. Carl Zeiss Meditec has a 12-month low of €37.53 ($42.65) and a 12-month high of €55.25 ($62.78).

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Recommended Story: Understanding Analyst Ratings

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.